GB0812642D0 - Compounds - Google Patents

Compounds

Info

Publication number
GB0812642D0
GB0812642D0 GBGB0812642.7A GB0812642A GB0812642D0 GB 0812642 D0 GB0812642 D0 GB 0812642D0 GB 0812642 A GB0812642 A GB 0812642A GB 0812642 D0 GB0812642 D0 GB 0812642D0
Authority
GB
United Kingdom
Prior art keywords
compounds
obesity
diabetes
useful
formula
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB0812642.7A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Prosidion Ltd
Original Assignee
Prosidion Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Prosidion Ltd filed Critical Prosidion Ltd
Priority to GBGB0812642.7A priority Critical patent/GB0812642D0/en
Publication of GB0812642D0 publication Critical patent/GB0812642D0/en
Priority to PCT/GB2009/050829 priority patent/WO2010004346A1/en
Priority to EP09785307A priority patent/EP2318399B1/en
Priority to AT09785307T priority patent/ATE557023T1/de
Priority to US13/003,569 priority patent/US20110195994A1/en
Priority to CN2009801269915A priority patent/CN102089299A/zh
Priority to JP2011517247A priority patent/JP2011527333A/ja
Priority to ES09785307T priority patent/ES2386870T3/es
Priority to HK11111531.0A priority patent/HK1157329B/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Child & Adolescent Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
GBGB0812642.7A 2008-07-10 2008-07-10 Compounds Ceased GB0812642D0 (en)

Priority Applications (9)

Application Number Priority Date Filing Date Title
GBGB0812642.7A GB0812642D0 (en) 2008-07-10 2008-07-10 Compounds
PCT/GB2009/050829 WO2010004346A1 (en) 2008-07-10 2009-07-10 Piperidinyl gpcr agonists
EP09785307A EP2318399B1 (en) 2008-07-10 2009-07-10 Piperidinyl gpcr agonists
AT09785307T ATE557023T1 (de) 2008-07-10 2009-07-10 Piperidinylverbindungen als gpcr-agonisten
US13/003,569 US20110195994A1 (en) 2008-07-10 2009-07-10 Piperidinyl GPCR Agonists
CN2009801269915A CN102089299A (zh) 2008-07-10 2009-07-10 哌啶基gpcr激动剂
JP2011517247A JP2011527333A (ja) 2008-07-10 2009-07-10 ピペリジニルｇｐｃｒ作動薬
ES09785307T ES2386870T3 (es) 2008-07-10 2009-07-10 Agonistas de GPCR piperidinilo
HK11111531.0A HK1157329B (en) 2008-07-10 2009-07-10 Piperidinyl gpcr agonists

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0812642.7A GB0812642D0 (en) 2008-07-10 2008-07-10 Compounds

Publications (1)

Publication Number Publication Date
GB0812642D0 true GB0812642D0 (en) 2008-08-20

Family

ID=39722068

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB0812642.7A Ceased GB0812642D0 (en) 2008-07-10 2008-07-10 Compounds

Country Status (8)

Country Link
US (1) US20110195994A1 (enExample)
EP (1) EP2318399B1 (enExample)
JP (1) JP2011527333A (enExample)
CN (1) CN102089299A (enExample)
AT (1) ATE557023T1 (enExample)
ES (1) ES2386870T3 (enExample)
GB (1) GB0812642D0 (enExample)
WO (1) WO2010004346A1 (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8481731B2 (en) 2009-06-24 2013-07-09 Boehringer Ingelheim International Gmbh Compounds, pharmaceutical composition and methods relating thereto
TW201111361A (en) 2009-06-24 2011-04-01 Boehringer Ingelheim Int New compounds, pharmaceutical composition and methods relating thereto
JP2013522279A (ja) 2010-03-18 2013-06-13 ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング 糖尿病及び関連状態の治療で用いるｇｐｒ１１９作動薬とｄｄｐ−ｉｖ阻害薬リナグリプチンの組合せ
TW201209054A (en) 2010-05-28 2012-03-01 Prosidion Ltd Novel compounds
US8530413B2 (en) 2010-06-21 2013-09-10 Sanofi Heterocyclically substituted methoxyphenyl derivatives with an oxo group, processes for preparation thereof and use thereof as medicaments
TW201215388A (en) 2010-07-05 2012-04-16 Sanofi Sa (2-aryloxyacetylamino)phenylpropionic acid derivatives, processes for preparation thereof and use thereof as medicaments
TW201215387A (en) 2010-07-05 2012-04-16 Sanofi Aventis Spirocyclically substituted 1,3-propane dioxide derivatives, processes for preparation thereof and use thereof as a medicament
TW201221505A (en) 2010-07-05 2012-06-01 Sanofi Sa Aryloxyalkylene-substituted hydroxyphenylhexynoic acids, process for preparation thereof and use thereof as a medicament
GB201114389D0 (en) 2011-08-22 2011-10-05 Prosidion Ltd Novel compounds
WO2012066077A1 (en) 2010-11-18 2012-05-24 Prosidion Limited 1,4 di substituted pyrrolidine - 3 - yl -amine derivatives and their use for the treatment of metabolic disorders
AU2012240122B2 (en) 2011-04-08 2016-08-25 Merck Sharp & Dohme Corp. Substituted cyclopropyl compounds, compositions containing such compounds and methods of treatment
EP2720544B1 (en) 2011-06-16 2016-12-21 Merck Sharp & Dohme Corp. Substituted cyclopropyl compounds, compositions containing such compounds, and methods of treatment
WO2013037390A1 (en) 2011-09-12 2013-03-21 Sanofi 6-(4-hydroxy-phenyl)-3-styryl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
WO2013045413A1 (en) 2011-09-27 2013-04-04 Sanofi 6-(4-hydroxy-phenyl)-3-alkyl-1h-pyrazolo[3,4-b]pyridine-4-carboxylic acid amide derivatives as kinase inhibitors
EP2760855B1 (en) 2011-09-30 2017-03-15 Merck Sharp & Dohme Corp. Substituted cyclopropyl compounds, compositions containing such compounds as well as their use in treating type-2 diabetes
EP2771000B1 (en) 2011-10-24 2016-05-04 Merck Sharp & Dohme Corp. Substituted piperidinyl compounds useful as gpr119 agonists
US9018224B2 (en) 2011-11-15 2015-04-28 Merck Sharp & Dohme Corp. Substituted cyclopropyl compounds useful as GPR119 agonists

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100042A (en) * 1993-03-31 2000-08-08 Cadus Pharmaceutical Corporation Yeast cells engineered to produce pheromone system protein surrogates, and uses therefor
US6221660B1 (en) * 1999-02-22 2001-04-24 Synaptic Pharmaceutical Corporation DNA encoding SNORF25 receptor
MX2007016508A (es) * 2005-06-30 2008-03-04 Prosidion Ltd Agonistas del receptor acoplado a la proteina g.
PE20081849A1 (es) * 2007-01-04 2009-01-26 Prosidion Ltd Derivados de piperidin-4-il-propoxi-benzamida como agonistas de gpcr

Also Published As

Publication number Publication date
HK1157329A1 (en) 2012-06-29
ES2386870T3 (es) 2012-09-04
EP2318399A1 (en) 2011-05-11
US20110195994A1 (en) 2011-08-11
EP2318399B1 (en) 2012-05-09
CN102089299A (zh) 2011-06-08
JP2011527333A (ja) 2011-10-27
ATE557023T1 (de) 2012-05-15
WO2010004346A1 (en) 2010-01-14

Similar Documents

Publication Publication Date Title
MX2009007180A (es) Agonistas del receptor acoplado a la proteina g de la piperidina.
GB0812642D0 (en) Compounds
SI2114933T1 (sl) Piperidinski gpcr-agonisti
ATE557024T1 (de) Piperidinverbindungen als gpcr-agonisten
WO2007003962A3 (en) Gpcr agonists
WO2007003961A3 (en) Gpcr agonists
MA32467B1 (fr) Derives de piperidinyle agonistes de gpcr
WO2007116229A8 (en) Heterocyclic gpcr agonists
MX2012000704A (es) Agonistas de gpr119.
TN2012000152A1 (en) Spiropiperidine compounds and pharmaceutical use thereof for treating diabetes
MY153915A (en) Organic compounds
WO2007116230A8 (en) Azetidine derivatives as g-protein coupled receptor (gpr119 ) agonists
MX2010009736A (es) Compuesto heterociclico.
IN2012DN03042A (enExample)
MX2008013196A (es) 5-amido-2-carboxiamida-indoles.
WO2010052144A3 (en) Neuropeptide-2-receptor (y-2r) agonists and uses thereof
MX2012004264A (es) Derivados de sulfoxidos para el tratamiento de tumores.
UA100527C2 (en) Benzothiazoles as ghrelin receptor modulators
TN2009000536A1 (en) Novel herbicides
EA201200868A1 (ru) Ингибиторы диацилглицеролацилтрансферазы
DE602008002598D1 (en) Cyclohexylderivate
MX2013014161A (es) Derivados de imidazol.
UA96967C2 (en) Piperidine gpcr agonists
JO2979B1 (en) Cyclopropyl compounds
TN2010000583A1 (en) Organic compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)